Our latest articles
Keeping community pharmacy informed since 1886
Expert insights on the pharmacological management of overweight and obesity
Professor John Dixon and experienced pharmacist Dr Irene Um discuss the growing health concern of overweight and obesity and its pharmacological management 25 September 2024 | 7-8.00PM AEST This webinar …
Advanced Practice Pioneers
We are seeking to identify pharmacy’s Advanced Practice Pioneers, and we want you to tell us who they are Each year we ask our readers to identify those who are …
Cost of medicinal cannabis has almost halved: Nguyen
Australians share affordability concerns over medicinal cannabis scripts, but leading pharmacist in the space says costs have “dramatically decreased” In a study of Australians who regularly use drugs led by …
Striking pharmacists need award that reflects reality: Simpson
As WA hospital pharmacists enter their second week of industrial action, AdPha warns that future care delivery is under threat Earlier this month (11 September 2024) Health Services Union WA …
‘There is time to intervene’
Naloxone should be provided to reverse overdoses from both prescribed and illicit opioids, and pharmacists are at the forefront, experts urge Research shows that it is unusual for a person …
‘Substantial’ rise in private scripts for opioids
A decline in PBS dispensing of opioid analgesics has been offset by a marked rise in private scripts, particularly for immediate release formulations, new data shows Opioid use in Australia …
Placement poverty wipes student’s savings
Union calls for the expansion of Commonwealth Prac Payments to support more students undertaking mandatory unpaid placements Pharmacy students should not be excluded from the federal government’s placement support payments, …
Manufacturer to streamline insulin range
Pharmaceutical company announces plan to consolidate its range of insulin products to meet growing demand Novo Nordisk will discontinue eight of its insulin products – six of which are listed …
Research Roundup
Debbie Rigby rounds up the latest in research news Thoughtful prescription of inhaled medication has the potential to reduce inhaler-related greenhouse gas emissions by 85% The carbon footprint of inhaler …
Could buprenorphine patients prefer community pharmacy?
World-first research shows how community pharmacy depot buprenorphine services may help patients feel less stigmatised People who receive depot buprenorphine in community pharmacies have highlighted “hostile” and “judgemental” interactions when …
Work stress a factor in convicted pharmacist’s drinking
A pharmacist failed to report her conviction for drink driving causing grievous bodily harm on time, highlighting a lack of awareness of when to notify National Boards In May 2022, …
Temporary PBS listing for US product
Ongoing shortages of tenofovir with emtricitabine tablets prompt temporary PBS listing of alternative brand The Department of Health and Aged Care will temporarily list US approved medication, Emtricitabine and Tenofovir …
HM ConnecTED
While harm minimisation can be a turn-off conference topic for some, it is pharmacy’s equivalent of a must-see TED talk for others, says Angelo Pricolo Sometimes I listen to TED …
The week in review
Workplace issues were a major theme this week… from maternity discrimination, to pay, progression and fees This week we heard from PPA’s Leon Yap and PSS’ Kay Dunkley on the …